Mycobacterium tuberculosis (MT) infection poses a significant risk in immunocompromised individuals, particularly in areas with high MT prevalence. We describe the case of a 43-year-old heart transplant recipient who developed chronic sternal wound secretion post-transplant surgery. Imaging revealed signs of inflammatory tissue suggestive of chronic osteomyelitis. Removal of the sternal wires was performed, followed by biopsy, which identified granulomatous inflammatory tissue and Langhans cells, that led to the diagnosis of MT infection later confirmed in culture results. The patient completed a 6-month tetraconjugate antituberculous therapy, resulting in successful wound healing and infection resolution. Atypical extrapulmonary MT manifestations require high clinical suspicion, especially in immunocompromised patients, to ensure timely diagnosis and treatment with favorable outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaccas.2024.103088DOI Listing

Publication Analysis

Top Keywords

mycobacterium tuberculosis
8
inflammatory tissue
8
sternal osteomyelitis
4
osteomyelitis caused
4
caused mycobacterium
4
tuberculosis heart transplant
4
heart transplant patient
4
patient mycobacterium
4
tuberculosis infection
4
infection poses
4

Similar Publications

Introduction: Tuberculosis (TB), caused by the (M.tb), remains a serious medical concern globally. Resistant M.

View Article and Find Full Text PDF

We designed and synthesized pyrazolyl pyrimidine containing derivatives and screened for anti-mycobacterial activity. Different spectral techniques like HRMS, 1H, and 13C NMR are deployed for the structural confirmation of the final derivatives. Final compounds were screened against the Mycobacterium tuberculosis (Mtb) H37Rv strain.

View Article and Find Full Text PDF

Host-directed therapy in diabetes and tuberculosis comorbidity, towards global TB elimination.

Int J Infect Dis

March 2025

Centre for Inflammation Research and Translational Medicine, Department of Biosciences, Brunel University of London, United Kingdom. Electronic address:

Host-directed therapy could potentially revolutionise tuberculosis control, as adjunct to traditional antibiotics for the treatment of tuberculosis disease, and as a strategy to prevent disease progression following Mycobacterium tuberculosis infection. The growing type 2 diabetes pandemic is hampering tuberculosis control worldwide, as people with diabetes have an increased risk of developing tuberculosis disease as well as worse treatment outcomes. Pulmonary tuberculosis is characterised by an inflammatory response which can cause alveolar tissue destruction and cavitation, and this inflammation is exacerbated in people with tuberculosis-diabetes comorbidity.

View Article and Find Full Text PDF

Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis.

STAR Protoc

March 2025

Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain; CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address:

Here, we present a protocol to perform a time-kill assay (TKA) to quantify bacterial burden at multiple time points using colony-forming units and most probable number readouts simultaneously. We describe steps for preparing inoculum, experimental conditions, and sampling bacterial counts. We then detail procedures for quantification and analysis.

View Article and Find Full Text PDF

In this study, we designed and synthesized a new series of  isoniazid-dihydropyrimidinone molecular hybrids (8a-8n). All compounds were structurally characterized using spectroscopic techniques viz., FTIR, NMR (1H, 13C, HMBC, and HSQC), and HRMS followed by their in vitro anti-tubercular evaluation including their precursors (4a-4n), and a standard anti-tubercular drug (Isoniazid; INH).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!